Keyword: biopharmaceuticals

News

Fujifilm Invests $1.6 Billion for Cell Culture Expansion

14.07.2022 -

Fujifilm is preparing to invest $1.6 billion to ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.

Services

Optimal Time-to-Market for Life-Saving Biopharmaceuticals

Rentschler Biopharma SE -

Rentschler Biopharma offers bioprocess development and cGMP manufacturing for high-quality biopharmaceuticals. The company’s strength lies in its extensive experience...

Webinar Series: The Future of Scientific Product Innovation and Manufacturing in the Life Sciences Industry

18.05.2020 - Achieve business excellence with end-to-end scientific collaboration platform for faster drug-to-market & agile medical device manufacturing. Join us for our webinar series to...

News

Rentschler Kicks off Expansion at US Facility

29.11.2019 -

Laupheim, Germany-based contract development and manufacturing organization (CDMO) for biopharmaceuticals, Rentschler Biopharma, is taking the first step in the expansion...

Markets & Companies

Driving Innovation and Extending Its Global Reach

28.10.2019 -

Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."

News

Rentschler Biopharma Extends Japanese Pact

09.10.2019 -

German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with...

News

Boehringer Ingelheim Buys ViraTherapeutics

25.09.2018 - Boehringer Ingelheim has taken an option to buy all the shares of ViraTherapeutics, an Austrian biopharma that specializes in developing immunotherapy drugs based on oncolytic...

Markets & Companies

Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit

24.11.2017 - Of the remaining post-Brexit 27 member states of the European Union, Ireland looks likely to suffer the most economically, and also possibly politically, as a result of the UK’s...